Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 04/21/2023 | PUT | $146.00 | 977 | +823 | +534.42% |
| 05/12/2023 | PUT | $100.00 | 319 | +319 | |
| 04/21/2023 | CALL | $160.00 | 11,169 | +269 | +2.47% |
| 04/06/2023 | CALL | $157.50 | 404 | +192 | +90.57% |
| 04/06/2023 | PUT | $157.50 | 288 | +175 | +154.87% |
| 06/16/2023 | CALL | $165.00 | 6,857 | +151 | +2.25% |
| 03/31/2023 | PUT | $155.00 | 887 | -35 | -3.80% |
| 03/31/2023 | CALL | $155.00 | 1,418 | -38 | -2.61% |
| 01/17/2025 | CALL | $200.00 | 185 | -40 | -17.78% |
| 03/31/2023 | CALL | $160.00 | 3,062 | -52 | -1.67% |
| 03/31/2023 | CALL | $162.50 | 4,634 | -85 | -1.80% |
| 03/31/2023 | PUT | $152.50 | 275 | -99 | -26.47% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.98% | 52.74M | 8.41B |
| Vanguard 500 Index Fund | 2.27% | 40.08M | 6.39B |
| SPDR S&P 500 ETF Trust | 1.10% | 19.51M | 3.11B |
| Fidelity 500 Index Fund | 1.10% | 19.38M | 3.09B |
| American Mutual Fund Inc | 1.02% | 18M | 2.87B |
| iShares Core S&P 500 ETF | 0.90% | 15.88M | 2.53B |
| Vanguard Index-Value Index Fund | 0.88% | 15.51M | 2.47B |
| Capital Income Builder, Inc. | 0.87% | 15.3M | 2.44B |
| Washington Mutual Investors Fund | 0.83% | 14.72M | 2.35B |
| Select Sector SPDR Fund-Health Care | 0.83% | 14.61M | 2.33B |
These 5 High-Yield Dividend Stocks Should Make Me $3,000 in Passive Income This Year
04/02 05:50 am
The Motley Fool
Read moreCould This Drug News Lift AbbVie's Stock?
04/01 09:15 am
The Motley Fool
Read moreThe Top Healthcare Stocks to Buy With $100
03/31 10:00 am
The Motley Fool
Read moreThis Blockbuster Drug's Latest News Could Be Another Home Run for AbbVie
03/31 08:50 am
The Motley Fool
Read more2 High-Yielding Dividend Investments to Buy for the Long Haul
03/30 07:45 am
The Motley Fool
Read moreBetter Growth Stock: Vertex Pharmaceuticals vs. AbbVie
03/29 02:00 pm
The Motley Fool
Read moreBetter Growth Stock: AbbVie vs. Pfizer
03/29 07:30 am
The Motley Fool
Read more2 Relatively Safe Dividend Stocks You Won't Regret Owning
03/28 10:07 am
The Motley Fool
Read moreThis Is the Best Dividend ETF You Can Buy
03/28 08:13 am
The Motley Fool
Read moreAbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
03/27 05:45 pm
Zacks Investment Research
Read moreIs Big Pharma Coming For Your Cannabis Business?
03/27 02:01 pm
Benzinga
Read moreThe Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
03/27 07:41 am
Zacks Investment Research
Read moreI Own 12 High-Yield Dividend Stocks. Here's the Best of the Bunch.
03/25 05:52 am
The Motley Fool
Read moreBetter Buy: AbbVie vs. Johnson & Johnson
03/25 05:30 am
The Motley Fool
Read moreAbbVie (ABBV) Provides Clinical Updates on Inflammatory Drugs
03/24 12:56 pm
Zacks Investment Research
Read morePharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
03/24 09:04 am
Zacks Investment Research
Read moreThis Delivery Giant Is A 'Comeback Story' Plus Nike, AbbVie And Oracle: CNBC's 'Final Trades'
03/24 08:37 am
Benzinga
Read more3 Simple Ways to Supercharge Your Biopharma Investing Using Artificial Intelligence
03/24 08:20 am
The Motley Fool
Read more2 High-Yield Dividend Stocks You Won't Regret Buying Right Now
03/23 10:00 am
The Motley Fool
Read moreAbbVie (ABBV) Gets FDA Rejection for Parkinson's Candidate
03/23 09:51 am
Zacks Investment Research
Read more3 Things About AbbVie That Smart Investors Know
03/23 09:15 am
The Motley Fool
Read moreUse These 3 Strategies to Make $1,000 in Passive Income Per Year
03/23 06:15 am
The Motley Fool
Read more2 Reasons to Buy AbbVie, and 1 Reason to Sell
03/23 05:30 am
The Motley Fool
Read moreAbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
03/22 09:00 am
Zacks Investment Research
Read moreHere's What is Driving Amgen (AMGN) Stock's Outperformance
03/22 05:51 am
Zacks Investment Research
Read moreAbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know
03/20 05:45 pm
Zacks Investment Research
Read moreShould First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar?
03/20 06:20 am
Zacks Investment Research
Read moreShould You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?
03/20 06:20 am
Zacks Investment Research
Read more4 Top Value Stock ETFs for Long-Term Wealth Building
03/19 06:31 am
The Motley Fool
Read more2 Growth Stocks to Buy Before the Bull Market Arrives
03/16 08:30 am
The Motley Fool
Read moreThe Zacks Analyst Blog Highlights AbbVie, NextEra Energy, ConocoPhillips, Canadian Pacific Railway and Intercontinental Exchange
03/14 08:46 am
Zacks Investment Research
Read moreOracle, AbbVie And This Gold Fund: CNBC's 'Final Trades'
03/14 08:37 am
Benzinga
Read more5 Forever Dividend Stocks
03/14 07:00 am
The Motley Fool
Read moreAbbVie (ABBV) Gains As Market Dips: What You Should Know
03/13 05:45 pm
Zacks Investment Research
Read moreTop Research Reports for AbbVie, NextEra Energy & ConocoPhillips
03/13 01:10 pm
Zacks Investment Research
Read moreThe Near-Perfect Portfolio: Sleep Well During Turbulent Times
03/11 10:00 am
Seeking Alpha
Read more3 No-Brainer Dividend Stocks to Buy in March
03/11 07:14 am
The Motley Fool
Read moreInvestors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
03/10 10:00 am
Zacks Investment Research
Read moreZacks Investment Ideas feature highlights: Coca-Cola Company, AbbVie and Exxon Mobil
03/10 06:00 am
Zacks Investment Research
Read moreReap Monthly Income With This Combination of 3 Stocks
03/09 03:29 pm
Zacks Investment Research
Read moreIs WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now?
03/09 07:20 am
Zacks Investment Research
Read more3 Surefire Stocks That Are Screaming Buys in March
03/09 07:07 am
The Motley Fool
Read more3 High-Yield Dividend Stocks to Buy Before the Next Bull Rally
03/09 06:41 am
The Motley Fool
Read moreIs It Too Late to Buy AbbVie Stock?
03/09 06:30 am
The Motley Fool
Read moreMy Portfolio February Update: 4 Buys, 1 Sale
03/09 04:28 am
Seeking Alpha
Read moreShould WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?
03/07 07:20 am
Zacks Investment Research
Read more2 Top Dividend Kings to Buy for the Long Haul
03/04 10:53 am
The Motley Fool
Read more2 High-Yield Dividend Stocks to Buy in March
03/04 07:27 am
The Motley Fool
Read moreNearing retirement? Here’s how to transition your portfolio from growth to income.
03/03 06:26 pm
MarketWatch
Read moreCould This Humira Biosimilar Be a Winner for Amgen?
03/03 07:00 am
The Motley Fool
Read more